BET Inhibitor TEN-010

A small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins with potential antineoplastic activity. Upon administration, the BET inhibitor TEN-010 binds to the acetylated lysine recognition motifs found in the bromodomain of BET proteins, which prevents the interaction between BET proteins and acetylated histones. This interaction disrupts chromatin remodeling and gene expression. Prevention of the expression of certain growth-promoting genes may lead to an inhibition of tumor cell growth. Characterized by a tandem repeat of bromodomains at the N-terminus, BET proteins, comprised of BRD2, BRD3, BRD4 and BRDT, are transcriptional regulators that play an important role during cellular development and growth. (NCI Thesaurus)

YOU MAY ALSO LIKE

BET Inhibitor GSK525762

A small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins with potential antineoplastic activity. Upon administration, the BET…

BET Inhibitor CPI-0610

A small molecule inhibitor of the Bromodomain and Extra-Terminal (BET) family of proteins, with potential antineoplastic activity. Upon administration, the BET inhibitor…

BET Bromodomains 2/3/4 Inhibitor OTX015

A synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4 with potential antineoplastic…

Besunide

An aminosulfamoylbenzoic acid-based diuretic.

Besulpamide

A sulfamoylchlorobenzoic acid derivative with diuretic activity. Besulpamide appears to be similar in diuretic activity to that of chlorthalidone, clopamide and…

Best practice

Treatment that is accepted by medical experts as a proper treatment for a certain type of disease and that is widely used…